The mean change from baseline to week 12 in the number of migraine headache days was -42 ( SD 31 ; 625 % decrease ) in the LY2951742 group compared with -30 ( SD 30 ; 423 % decrease ) in the placebo group ( least-squares mean difference -12 , 90 % CI -19 to -06 ; p = 00030 ) .